IDEAYA Biosciences Inc (IDYA)
42.18
+0.69
(+1.66%)
USD |
NASDAQ |
May 03, 16:00
42.16
-0.02
(-0.05%)
After-Hours: 20:00
IDEAYA Biosciences Price to Book Value: 5.064 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 5.064 |
| May 02, 2024 | 4.981 |
| May 01, 2024 | 4.944 |
| April 30, 2024 | 4.880 |
| April 29, 2024 | 4.880 |
| April 26, 2024 | 4.795 |
| April 25, 2024 | 4.636 |
| April 24, 2024 | 4.784 |
| April 23, 2024 | 4.684 |
| April 22, 2024 | 4.513 |
| April 19, 2024 | 4.457 |
| April 18, 2024 | 4.516 |
| April 17, 2024 | 4.822 |
| April 16, 2024 | 4.942 |
| April 15, 2024 | 4.983 |
| April 12, 2024 | 5.038 |
| April 11, 2024 | 5.217 |
| April 10, 2024 | 5.078 |
| April 09, 2024 | 5.110 |
| April 08, 2024 | 5.041 |
| April 05, 2024 | 5.103 |
| April 04, 2024 | 4.97 |
| April 03, 2024 | 5.06 |
| April 02, 2024 | 4.982 |
| April 01, 2024 | 5.104 |
| Date | Value |
|---|---|
| March 28, 2024 | 5.268 |
| March 27, 2024 | 5.199 |
| March 26, 2024 | 5.103 |
| March 25, 2024 | 5.079 |
| March 22, 2024 | 5.166 |
| March 21, 2024 | 5.478 |
| March 20, 2024 | 5.379 |
| March 19, 2024 | 5.319 |
| March 18, 2024 | 5.217 |
| March 15, 2024 | 5.318 |
| March 14, 2024 | 5.378 |
| March 13, 2024 | 5.487 |
| March 12, 2024 | 5.373 |
| March 11, 2024 | 5.232 |
| March 08, 2024 | 5.469 |
| March 07, 2024 | 5.430 |
| March 06, 2024 | 5.565 |
| March 05, 2024 | 5.382 |
| March 04, 2024 | 5.615 |
| March 01, 2024 | 5.549 |
| February 29, 2024 | 5.366 |
| February 28, 2024 | 5.350 |
| February 27, 2024 | 5.451 |
| February 26, 2024 | 5.544 |
| February 23, 2024 | 5.508 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.614
Minimum
Mar 17 2020
5.658
Maximum
Feb 16 2024
2.536
Average
2.280
Median
Price to Book Value Benchmarks
| Merck & Co Inc | 8.594 |
| Pfizer Inc | 1.769 |
| Geron Corp | 6.759 |
| Verastem Inc | 4.808 |
| Karyopharm Therapeutics Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 103.70 |
| PEG Ratio | -0.5131 |
| Price | 42.18 |
| Earnings Yield | -4.67% |
| Market Cap | 3.145B |
| PEGY Ratio | -0.5131 |